Dr. Patrik Frei is founder and CEO of Venture Valuation AG, Switzerland, the company he started in 1999 based on collaboration with the Novartis Venture Fund. Since then he has been involved in over 700 valuations around the globe for investors as well as Biotech, Pharma and Medtech companies. Patrik has experience as a board member of public and private companies, published numerus articles and provides valuation workshops around the world.